Search
for
Sort by
Research 451–480 of 1000+
- Current treatment of BPH
- Guidelines on the use of finasteride in androgenetic alopecia
- New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide)
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Provenge is Talk of GU Malignancies Congress
- Level-1 Data From the REDUCE Study and the PCPT Data
- Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- Primärprävention urologischer Tumore: Prostatakarzinom
- Off-label prescriptions: patient safety first
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I
- Étude PCPT : les biais attendus et leur gestion
- Abstract 2205: KRTAP 2-3 is a novel potential biomarker of cells in the polyaneuploid cancer cell (PACC) state to predict cancer recurrence
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro
- Omega-6 highly unsaturated fatty acids in Leydig cells facilitate male sex hormone production
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- Study Answers Some Questions about Androgen Suppression Pre-Radiation, but Not All
- An exclusive review of melatonin effects on mammalian melanocytes and melanoma
- Intracavernous injection of platelet‐rich plasma reverses erectile dysfunction of chronic cavernous nerve degeneration through reduction of prostate hyperplasia evidence from an aging‐induced erectile dysfunction rat model
- A systematic review on the lipid composition of human hair
- Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia